An article in the April 15, 1999, issue of BioWorld Today should have said PG-TXL, a water-soluble form of Taxol, was developed at the M.D. Anderson Cancer Center, in Houston, which licensed it to Cell Therapeutics Inc.
All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
An article in the April 15, 1999, issue of BioWorld Today should have said PG-TXL, a water-soluble form of Taxol, was developed at the M.D. Anderson Cancer Center, in Houston, which licensed it to Cell Therapeutics Inc.